Cite
Can Ruxolitinib Crash TET2- and IDH2-Driven Clonal Hematopoiesis?
MLA
Khabusheva, Elmira, and Margaret A. Goodell. “Can Ruxolitinib Crash TET2- and IDH2-Driven Clonal Hematopoiesis?” Cancer Discovery, vol. 14, no. 10, Oct. 2024, pp. 1768–70. EBSCOhost, https://doi.org/10.1158/2159-8290.CD-24-1020.
APA
Khabusheva, E., & Goodell, M. A. (2024). Can Ruxolitinib Crash TET2- and IDH2-Driven Clonal Hematopoiesis? Cancer Discovery, 14(10), 1768–1770. https://doi.org/10.1158/2159-8290.CD-24-1020
Chicago
Khabusheva, Elmira, and Margaret A Goodell. 2024. “Can Ruxolitinib Crash TET2- and IDH2-Driven Clonal Hematopoiesis?” Cancer Discovery 14 (10): 1768–70. doi:10.1158/2159-8290.CD-24-1020.